Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-091154
Filing Date
2025-06-27
Accepted
2025-06-27 19:53:28
Documents
1
Period of Report
2025-06-25

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3856
  Complete submission text file 0000950170-25-091154.txt   5559
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 239-2030
Senti Biosciences, Inc. (Issuer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O SENTI BIOSCIENCES, INC. 2 CORPORATE DRIVE FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
COOPERSTONE BRENDA (Reporting) CIK: 0001931514 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40440 | Film No.: 251088459